Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics
APRIL 2009 IS ON ITS WAY TO BECOMING A MILESTONE MONTH for the laboratory testing industry. On April 15, even as corporate officials from Quest Diagnostics Incorporated were walking into a federal courthouse to plead guilty to a criminal felony charge, health officials in Mexico were in the first stages of identifying a new, troubling …
A Guilty Plea and A Global Flu Emergency Read More »
CEO SUMMARY: In recent weeks, health authorities in Mexico became aware of a new strain of influenza, A/H1N1, because of unexpected deaths from “atypical pneumonia.” As early as April 19, the CDC had identified similar cases in Texas and California. By last Friday, WHO, Canada’s PHAC, and the CDC had posted public alerts about this …
Puzzling New Flu Strain Causes Concern in Mexico Read More »
HAVING WON a significant court ruling last spring that stopped the Medicare Laboratory Testing Competitive Bidding Demonstration Project dead in its tracks, three San Diego-area laboratories are scheduled to return to court today. Important legal issues still need resolution. At today’s scheduled hearing, the three plaintiff laboratories—Sharp HealthCare, Scripps Health, and Internist Laboratory of Oceanside, …
San Diego Labs Pursue Return of Bids from Medicare Officials Read More »
CEO SUMMARY: Proud of a 73% reduction in mortality among patients with coronary artery disease (CAD) at Kaiser Permanente Colorado, clinical care teams there demonstrate how integrated care and more effective use of laboratory test data can lead to remarkable improvements in patient outcomes. Key themes in this achievement are the combined use of an …
Kaiser in Colorado Uses Lab Test Data to Improve Cardiac Care Read More »
CEO SUMMARY: Over the past two decades, investor-owned anatomic pathology companies captured significant market share from community hospital-based pathology groups while delivering profits to their owners. Despite the recent downturn in the economy, Wall Street believes histology laboratories remain an attractive investment for investors. Financial analyst Kemp Dolliver explains the reasons why professional investors remain …
Why Wall Street Likes Histology Lab Business Read More »
As unemployment rates climb in the United States, employers are ordering fewer pre-employment drugs of abuse (DOA) screening panels. This is expected. It is why investors know that drugs-of-abuse volumes are closely linked to the economic boom/bust cycle. During first quarter earning calls, public lab companies revealed the bad news in this sector of lab …
April 27, 2009 “Intelligence: Late Breaking Lab News” Read More »
The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: info@darkreport.com
© 2024 The Dark Report. All rights reserved.